Adverse drug reactions - PubMed (original) (raw)

Review

Adverse drug reactions

M Pirmohamed et al. BMJ. 1998.

No abstract available

PubMed Disclaimer

Similar articles

• Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.
  Ju C, Uetrecht JP. Ju C, et al. Curr Drug Metab. 2002 Aug;3(4):367-77. doi: 10.2174/1389200023337333. Curr Drug Metab. 2002. PMID: 12093356 Review.
• Role of bioactivation in drug-induced hypersensitivity reactions.
  Sanderson JP, Naisbitt DJ, Park BK. Sanderson JP, et al. AAPS J. 2006 Feb 3;8(1):E55-64. doi: 10.1208/aapsj080107. AAPS J. 2006. PMID: 16584134 Free PMC article. Review.
• Metabolomics in drug intolerance.
  Andreu I, Mayorga C, Miranda MA. Andreu I, et al. Curr Drug Metab. 2009 Nov;10(9):947-55. doi: 10.2174/138920009790711823. Curr Drug Metab. 2009. PMID: 20214587 Review.
• Metabolic activation in drug allergies.
  Park BK, Naisbitt DJ, Gordon SF, Kitteringham NR, Pirmohamed M. Park BK, et al. Toxicology. 2001 Feb 2;158(1-2):11-23. doi: 10.1016/s0300-483x(00)00397-8. Toxicology. 2001. PMID: 11164988 Review.
• Reactive metabolites and adverse drug reactions: clinical considerations.
  Knowles SR, Shapiro LE, Shear NH. Knowles SR, et al. Clin Rev Allergy Immunol. 2003 Jun;24(3):229-38. doi: 10.1385/CRIAI:24:3:229. Clin Rev Allergy Immunol. 2003. PMID: 12721394 Review.

Cited by

• The development and evaluation of triage algorithms for early discovery of adverse drug interactions.
  Strandell J, Caster O, Hopstadius J, Edwards IR, Norén GN. Strandell J, et al. Drug Saf. 2013 May;36(5):371-88. doi: 10.1007/s40264-013-0053-7. Drug Saf. 2013. PMID: 23640657
• Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.
  Roychowdhury S, Svensson CK. Roychowdhury S, et al. AAPS J. 2005 Dec 9;7(4):E834-46. doi: 10.1208/aapsj070480. AAPS J. 2005. PMID: 16594635 Free PMC article. Review.
• Consultations owing to adverse drug reactions in a single practice.
  Millar JS. Millar JS. Br J Gen Pract. 2001 Feb;51(463):130-1. Br J Gen Pract. 2001. PMID: 11217627 Free PMC article.
• Polypharmacy: a healthcare conundrum with a pharmacogenetic solution.
  Sharp CN, Linder MW, Valdes R Jr. Sharp CN, et al. Crit Rev Clin Lab Sci. 2019 Nov 2;57(3):161-180. doi: 10.1080/10408363.2019.1678568. Crit Rev Clin Lab Sci. 2019. PMID: 31680605 Free PMC article.
• Discovering Links Between Side Effects and Drugs Using a Diffusion Based Method.
  Timilsina M, Tandan M, d'Aquin M, Yang H. Timilsina M, et al. Sci Rep. 2019 Jul 18;9(1):10436. doi: 10.1038/s41598-019-46939-6. Sci Rep. 2019. PMID: 31320740 Free PMC article.

References

1. 1. Asscher AW, Parr GD, Whitmarsh VB. Towards the safer use of medicines. BMJ. 1995;311:1003–1005. - PMC - PubMed
2. 1. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? J R Coll Physicians Lond. 1995;29:41–49. - PMC - PubMed
3. 1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27:832–840. - PubMed
4. 1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events—implications for prevention. JAMA. 1995;274:29–34. - PubMed
5. 1. Bates DW, Spell N, Cuilen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307–311. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information